ASLAN Pharmaceuticals Ltd (ASLN)
0.4471
-0.01
(-2.78%)
USD |
NASDAQ |
May 03, 16:00
0.4539
+0.01
(+1.52%)
After-Hours: 20:00
ASLAN Pharmaceuticals Enterprise Value: 15.46M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 15.46M |
| May 02, 2024 | 15.75M |
| May 01, 2024 | 15.69M |
| April 30, 2024 | 15.76M |
| April 29, 2024 | 15.69M |
| April 26, 2024 | 14.74M |
| April 25, 2024 | 15.48M |
| April 24, 2024 | 15.98M |
| April 23, 2024 | 15.96M |
| April 22, 2024 | 15.64M |
| April 19, 2024 | 16.93M |
| April 18, 2024 | 17.57M |
| April 17, 2024 | 16.46M |
| April 16, 2024 | 16.47M |
| April 15, 2024 | 16.78M |
| April 12, 2024 | 16.66M |
| April 11, 2024 | 17.57M |
| April 10, 2024 | 17.36M |
| April 09, 2024 | 18.24M |
| April 08, 2024 | 17.79M |
| April 05, 2024 | 17.57M |
| April 04, 2024 | 16.89M |
| April 03, 2024 | 17.35M |
| April 02, 2024 | 18.24M |
| April 01, 2024 | 18.93M |
| Date | Value |
|---|---|
| March 28, 2024 | 19.27M |
| March 27, 2024 | 19.62M |
| March 26, 2024 | 19.71M |
| March 25, 2024 | 20.13M |
| March 22, 2024 | 20.12M |
| March 21, 2024 | 21.07M |
| March 20, 2024 | 21.39M |
| March 19, 2024 | 21.41M |
| March 18, 2024 | 23.44M |
| March 15, 2024 | 20.05M |
| March 14, 2024 | 19.49M |
| March 13, 2024 | 18.54M |
| March 12, 2024 | 17.40M |
| March 11, 2024 | 34.03M |
| March 08, 2024 | 16.35M |
| March 07, 2024 | 16.61M |
| March 06, 2024 | 17.12M |
| March 05, 2024 | 15.58M |
| March 04, 2024 | 16.70M |
| March 01, 2024 | 17.91M |
| February 29, 2024 | 20.83M |
| February 28, 2024 | 17.66M |
| February 27, 2024 | 13.70M |
| February 26, 2024 | 12.79M |
| February 23, 2024 | 12.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-25.88M
Minimum
Jun 07 2022
284.02M
Maximum
Mar 18 2021
54.28M
Average
44.93M
Median
Jul 06 2023
Enterprise Value Benchmarks
| Dr Reddy's Laboratories Ltd | 11.85B |
| Concord Medical Services Holdings Ltd | 996.09M |
| WAVE Life Sciences Ltd | 550.47M |
| Zai Lab Ltd | 805.69M |
| CytoMed Therapeutics Ltd | 17.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.51M |
| Total Expenses (Quarterly) | 12.77M |
| EPS Diluted (Quarterly) | -0.75 |
| Earnings Yield | -584.8% |
| Normalized Earnings Yield | -696.64 |